ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.98
◽
2020
◽
Vol 4
(6)
◽
pp. s98
Author(s):
Jonathan I. Silverberg
◽
Michael Cork
◽
Andreas Wollenberg
◽
Norito Katoh
◽
Louise Abildgaard Steffensen
◽
...
Keyword(s):
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Pivotal Phase
Abstract not available.
Download Full-text
Related Documents
Cited By
References
15054 Impact of baricitinib on patient-reported skin symptoms, itch, and quality of life in adult patients with moderate to severe atopic dermatitis and an inadequate response to topical therapies from phase 3 trials BREEZE-AD1 and BREEZE-AD2
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2020.06.198
◽
2020
◽
Vol 83
(6)
◽
pp. AB28
Author(s):
Peter Lio
◽
Audrey Nosbaum
◽
Tracy Cardillo
◽
Amy DeLozier
◽
Margaret Gamalo
◽
...
Keyword(s):
Quality Of Life
◽
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Inadequate Response
◽
Phase 3
◽
Skin Symptoms
◽
Patient Reported
Download Full-text
Use of Topical Corticosteroids with Tralokinumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.99
◽
2020
◽
Vol 4
(6)
◽
pp. s99
Author(s):
Jonathan Silverberg
◽
Andrew Pink
◽
Christina Olsen
◽
Stephan Weidinger
Keyword(s):
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Topical Corticosteroids
Abstract not available.
Download Full-text
Safety of Specifically Targeting Interleukin 13 with Tralokinumab in Adult Patients with Moderate-To-Severe Atopic Dermatitis: Pooled Analysis of Five Randomized, Double-Blind, Placebo-Controlled Phase 3 and Phase 2 Trials
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.5.supp.11
◽
2021
◽
Vol 5
(1)
◽
pp. s11
Author(s):
Eric Simpson
◽
Joseph Merola
◽
Jonathan Silverberg
◽
Rebecca Zachariae
◽
Rebecca Olsen
◽
...
Keyword(s):
Atopic Dermatitis
◽
Pooled Analysis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Phase 2
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
◽
Interleukin 13
Abstract not available.
Download Full-text
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)
SSRN Electronic Journal
◽
10.2139/ssrn.3748383
◽
2020
◽
Author(s):
Kristian Reich
◽
Henrique D. Teixeira
◽
Marjolein de Bruin-Weller
◽
Thomas Bieber
◽
Weily Soong
◽
...
Keyword(s):
Atopic Dermatitis
◽
Controlled Study
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
Pivotal Phase
◽
Double Blind
◽
Safety And Efficacy
◽
Double Blind Placebo
◽
Topical Corticosteroids
◽
Adolescents And Adults
Download Full-text
26053 Improvement in sleep is associated with improved quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a phase 3 trial of baricitinib therapy
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2021.06.080
◽
2021
◽
Vol 85
(3)
◽
pp. AB14
Author(s):
Peter Lio
◽
George Han
◽
Edward Lain
◽
Catherine Maari
◽
Susan Ball
◽
...
Keyword(s):
Quality Of Life
◽
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Phase 3
Download Full-text
26292 Rapid improvement in skin pain, and its impact on quality of life, in adult patients with moderate-to-severe atopic dermatitis from a double-blind, placebo-controlled baricitinib phase 3 study
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2021.06.402
◽
2021
◽
Vol 85
(3)
◽
pp. AB96
Author(s):
David Rosmarin
◽
Scott Fretzin
◽
Lindsay Strowd
◽
Marta Casillas
◽
Amy DeLozier
◽
...
Keyword(s):
Quality Of Life
◽
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Rapid Improvement
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
◽
Skin Pain
Download Full-text
Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.102
◽
2020
◽
Vol 4
(6)
◽
pp. s102
Author(s):
Stephan Weidinger
◽
Jonathan Silverberg
◽
Darryl Toth
◽
Thomas Bieber
◽
Andrew Alexis
◽
...
Keyword(s):
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Phase 3
◽
Topical Corticosteroids
Abstract not available.
Download Full-text
Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2)
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.96
◽
2020
◽
Vol 4
(6)
◽
pp. s96
Author(s):
Eric Simpson
◽
Andrew Blauvelt
◽
Emma Guttman-Yassky
◽
Margitta Worm
◽
Charles Lynde
◽
...
Keyword(s):
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Phase 3
Abstract not available.
Download Full-text
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy
Journal of Dermatological Treatment
◽
10.1080/09546634.2021.1914308
◽
2021
◽
pp. 1-6
Author(s):
Peter A. Lio
◽
Eric L. Simpson
◽
George Han
◽
Jennifer Soung
◽
Susan Ball
◽
...
Keyword(s):
Quality Of Life
◽
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Phase 3
Download Full-text
15058 The effect of baricitinib on daily and workplace activity from phase 3 trials BREEZE-AD1 and BREEZE-AD2 in adult patients with moderate to severe atopic dermatitis
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2020.06.648
◽
2020
◽
Vol 83
(6)
◽
pp. AB140
Author(s):
Lawrence F. Eichenfield
◽
Jonathan I. Silverberg
◽
José-Manuel Carrascosa
◽
Diana Rubel
◽
Steven Watts
◽
...
Keyword(s):
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Phase 3
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close